Ads
related to: humira treatment for crohn's disease cdc- Treatment Videos
Watch Videos To Learn More
About A Treatment Option.
- Dosing Information
Learn About The Dosing & Injection
Schedule For A CD Treatment.
- View Head-To-Head Data
Visit To Find Head-To-Head Data
For A Crohn's Disease Treatment.
- Treatment Safety Info
Learn About Long Term Safety Data
For A Crohn's Disease Treatment.
- Watch Videos For HCPs
Visit To Find The Video Library
For More Information.
- Contact A Rep
Contact A Representative To
Learn About A CD Treatment Option.
- Treatment Videos
Search results
Results From The WOW.Com Content Network
Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.
Crohn’s disease is a type of inflammatory bowel disease (IBD). It can cause inflammation to any part or layer of your bowel, although most often, it affects the end of your small bowel to the ...
Maintenance of remission after surgery for Crohn's disease [12] A combination of azathioprine and infliximab treatment may be more effective than a single dose of infliximab to induce steroid-free remission for people with active Crohn's disease. [9] Azathioprine treatment may lead to rare but life-threatening side effects.
It was initially used in the treatment of rheumatoid arthritis, but it is now also used in patients with moderate-to-severe Crohn's disease and ulcerative colitis who don't respond well to conventional treatment. [11] Adalimumab showed effectiveness in patients with Crohn's disease, but less than that of infliximab. [24]
Although the use of the term DMARDs was first propagated in rheumatoid arthritis (hence their name), the term has come to pertain to many other diseases, such as Crohn's disease, lupus erythematosus, Sjögren syndrome, immune thrombocytopenic purpura, myasthenia gravis, sarcoidosis, and various others. [citation needed]
Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, also sends Crohn's disease into clinical remission, new findings suggest.
Ads
related to: humira treatment for crohn's disease cdc